Novo Nordisk NVO announced disappointing data from a phase III study on a novel obesity candidate, CagriSema. Roche RHHBY ...
Sun Pharmaceutical Industries announces acquisition of US-based Checkpoint Therapeutics for up to USD 355 million. The Indian ...